You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 52 No. 11, November 1995 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contributions
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (18)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma and Red Blood Cell Thiamine Deficiency in Patients With Dementia of the Alzheimer's Type

Michael Gold, MD; Marianne F. Chen, DSc; Kathy Johnson, ARNP

Arch Neurol. 1995;52(11):1081-1086.


Abstract



Objectives
To determine the prevalence of plasma thiamine deficiency in patients referred to a memory disorder clinic and to compare plasma thiamine levels with red blood cell (RBC) thiamine levels. To determine if patients with senile dementia of the Alzheimer's type (SDAT) differ from those without SDAT in either plasma or RBC thiamine levels.

Design
Case-control study.

Setting
Ambulatory care referral center.

Patients
Consecutive sample of 34 patients; 17 patients who met the National Institute of Neurological and Communicative Disorders and Stroke—Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer's disease and 17 patients with other forms of dementia.

Methods
Plasma and RBC thiamine levels were determined in all patients with the use of a microbiologic assay known for its specificity to biological forms of thiamine. Vitamin supplementation was determined by chart

Outcome Measures
Plasma and RBC thiamine levels.

Results
Patients with SDAT were found to have significantly lower plasma thiamine levels than patients without SDAT. Low plasma thiamine levels were detected in a significantly larger proportion of patients with SDAT than in patients without SDAT. Red blood cell thiamine levels did not correlate with the clinical diagnosis of SDAT. Vitamin supplementation did not correlate with diagnosis and plasma or RBC thiamine levels.

Conclusions
A significant proportion of patients with SDAT may have a thiamine deficiency, which may have an impact on cognitive function. Currently used assays may not be adequate to assess thiamine status.



Author Affiliations



From the Departments of Neurology (Dr Gold) and Internal Medicine, Division of Digestive Diseases and Nutrition (Dr Chen), and Memory Disorder Clinic (Ms Johnson), University of South Florida College of Medicine, Tampa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Declaration of Nutrition, Health, and Intelligence for the Child-to-Be: Adapted from the Declaration of Olympia on Nutrition and Fitness, 28-29 May 1996 in Ancient Olympia, Greece, an Article by Artemis P. Simopoulos, MD, The Center for Genetics, Nutrition and Health, Washington, DC, USA
Katzen-Luchenta
Nutrition and Health 2007;19:85-102.
ABSTRACT  

Is B Vitamins Deficiency Associated with Prevalence of Alzheimer's Disease in Cuban Elderly?
Lanyau Dominguez et al.
Nutrition and Health 2006;18:103-118.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.